Dr. Chapa’s Clinical Pearls. Antenatal Steroids, and Baby Brains, Oh-MY!
Jun 15, 2025
Dive into the evolving world of antenatal corticosteroids and their role in fetal lung maturation and neurodevelopment. The discussion centers on new research highlighting the effects of timing on both lung benefits and neurodevelopmental outcomes. Humor lightens the exploration of medical guidelines, as experts dissect the balance between benefits and risks. Recent studies spark debate on safety and efficacy, making for a thought-provoking conversation around prenatal care.
AI Snips
Chapters
Transcript
Episode notes
Expanded Dose-to-Delivery Window
- The traditionally accepted 48 hours to 7 days is a likely maximal benefit window for antenatal corticosteroid effects.
- However, benefit can occur as early as 2-3 hours and last up to 14 days, challenging current clinical timing assumptions.
Possible Neurodevelopmental Risks
- Exposure to antenatal corticosteroids may be linked to an increased risk of neurocognitive or psychological impairments in children born late preterm or full term.
- The association has a modest hazard ratio of about 1.47, indicating elevated but not extreme risk.
Gestational Age Matters for Steroids
- Neurodevelopmental effects of antenatal steroids may depend on gestational age at exposure.
- Early exposure is neuroprotective, while late exposure could interfere with brain maturation processes like myelination.